Paradigm Convergence Technologies Corp Ltd
Ticker Symbol: PCTL
4235 Commerce Street. Little River, SC 29566
Phone: 843-390-7900 Fax: 843-390-2327
OTC Markets Status: Pink Current Info 4/15/21
OTC Markets Financials: Current as of 4/15/21
Latest PCTL News for Shareholders and New Investors NEWS OUT: April 15, 2021: PCT LTD Announces Fiscal 2020 Results: https://www.businesswire.com/news/home/20210415005316/en/ NEWS OUT: Jan. 7, 2021: https://www.wmbfnews.com/video/2021/01/07/donations-keep-local-shelters-clean-amid-covid-pandemic/?fbclid=IwAR1H706biU6i6_Y9ghL1PJBwq1DufZYBg6HQlxMOWTA3YCtBMhQbjxycjX0
April 15, 2021 08:15 AM Eastern Daylight Time
LITTLE RIVER, S.C.--(BUSINESS WIRE)--PCT LTD (OTC Pink: “PCTL”), reported financial results for the fiscal year ended December 31, 2020.
2020 Key Financial Highlights:
- Revenues for the year ended December 31, 2020 increased 255% to $2.5 million, as compared to $708 thousand in fiscal 2019. The revenue increase in 2020 was due to the increased volume of fluids sold during the COVID-19 pandemic, the sale of fluid-producing equipment, licensing revenue from EPA sub-registrations, and placing equipment under the Company’s 2- and 3-year Systems Service Agreements during the year.
- Net loss attributable to common stockholders decreased 43% to $8.1 million, as compared to $14.4 million in fiscal 2019. The net loss for 2020 was mainly due to more personnel, leased facilities, and higher accounting and legal expense, as well as continued development of next generation models(s) of the Company’s Annihilyzer® and other equipment.
Gary Grieco, PCTL’s Chairman and Chief Executive Officer stated, “I want to thank our partners and employees for their efforts to ensure the customers we serve and the communities where we have a presence throughout the globe, that our operations are in accordance with COVID-19 protocols. Throughout 2020, we expanded our business model while operating under the challenges posed by the COVID-19 pandemic. Our 2020 accomplishments, specifically the revenue increase, can be attributed to our sales and marketing efforts and our products meeting the unique needs of our customers.” Grieco further commented, “Although we fell short of our revenue goals, the Board is confident in the changes they are making to the business model and has voted to hire key personnel in the areas of Manufacturing and Sales & Marketing. The next 6 months will be all about supporting our Distributors and implementing policies and procedures to aggressively grow our topline and capture market share.”
Mr. Grieco continued, “As we focus on 2021 and beyond, we are experiencing opportunities in product lines and global distribution. Although we are competing with larger companies in many markets, our competitive advantage is that we are an environmentally-responsible company that has successfully increased installations in various markets while being less expensive. Quality, innovation, and value remain our guiding lights in this fast-paced expansion period. We continue to simplify how we do business, dramatically improving our execution and innovating faster than ever.”
“We are looking forward to the future as we carefully and strategically plan to expand our operations and meet the demand of our partners and customers. We believe that the heightened safety protocols to sanitize and disinfect surfaces in our Hospitals, Health Care Facilities and Schools will be enforced for an extended period. This demand will enable us to expand our current customer base as well as capture new customers through our competitive advantages in price and our products’ environmentally friendly properties. Additionally, we will be announcing the results of our oil and gas enhanced recovery study and an aggressive marketing campaign with our distributors to pursue the opportunities we see in that sector for our Hydrolyte and Catholyte products,” concluded Mr. Grieco.
About PCT LTD:
PCT LTD (“PCTL”) focuses its business on acquiring, developing, and providing sustainable, environmentally responsible disinfecting, cleaning and tracking technologies. The Company acquires and holds rights to innovative products and technologies, which are commercialized through its wholly owned operating subsidiary, Paradigm Convergence Technologies Corporation (PCT Corp). The Company established entry into its target markets with commercially viable products in the United States and now continues to gain market share in the U.S. and U.K.
www.pctcorporation.com (Distributor-focused website)
www.para-con.com (PCT LTD, Investor-focused website)
www.pctcorphealth.com (Healthcare Market-focused website)
This press release contains “forward-looking statements” as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21B of the Securities Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be “forward-looking statements.”
Such statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Such statements involve risks and uncertainties, including but not limited to: PCTL's ability to raise sufficient funds to satisfy its working capital requirements; the ability of PCTL to execute its business plan; the anticipated results of business contracts with regard to revenue; and any other effects resulting from the information disclosed above; risks and effects of legal and administrative proceedings and government regulation; future financial and operational results; competition; general economic conditions; and the ability to manage and continue growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. Important factors that could cause actual results to differ materially from the forward-looking statements PCTL makes in this press release include market conditions and those set forth in reports or documents it files from time to time with the SEC. PCTL undertakes no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
Investor Relations Contact:
Tel: (760) 621-0062
PCT Ltd. (PCTL) Executes 1 Million Gallon Minimum Annual Supply Agreement; Company Anticipates Record Setting Revenues for 4th Quarter
LITTLE RIVER, SC -- October 27, 2020 -- InvestorsHub NewsWire -- PCT LTD (OTC Pink: PCTL) today announced that it has executed a domestic supply agreement with Maverick Energy Services and Maverick Environmental Solutions of Holdenville, Oklahoma for a minimum of 1,000,000 gallons of PCT Hydrolyte® to be delivered over the next twelve months. An initial order has been fulfilled on this contract. We would also like to update our shareholders on PCTL's revenue guidance for the fiscal year of 2020. We continue to anticipate revenues of approximately $4 million. In addition, we expect to achieve record-setting revenues during the 4th quarter of 2020.
About Maverick Energy Services and Maverick Environmental Solutions, LLC:
Both companies were developed by Mr. Doug Humphreys. Mr. Humphreys graduated in 1975 from Southwest Oklahoma University with degrees in Business Administration and Geology. Mr. Humphreys began his career in 1977 with Tide West Oil Company, formerly Flint & Associates. From 1977 – 1997, Mr. Humphreys had a personal role in the development of over 1,500 wells at various depths of up to 20,000 plus feet. Over his career, he was employed with various oil and gas companies, including Tide West Oil Company, Square D Drilling, Kerr-McGee, focused in Texas, New Mexico, Louisiana, Kansas and Oklahoma. In 2007, Mr. Humphreys started Maverick Energy Services, LLC and in 2019, Maverick Environmental Services, LLC. Mr. Humphreys currently serves on the board of The First National Bank of Holdenville, Oklahoma, serves on the foundation board of Seminole State College, is a member of OIPA and is a well-known figure within oil and gas circles.
About PCT Ltd:
PCT LTD ("PCTL") focuses its business on acquiring, developing and providing sustainable, environmentally safe disinfecting, cleaning and tracking technologies. The company acquires and holds rights to innovative products and technologies, which are commercialized through its wholly-owned operating subsidiary, Paradigm Convergence Technologies Corporation (PCT Corp). Currently trading on OTC:PINK, "PCTL" is actively engaged in applying for listing its common stock to the OTC QB market. The Company established entry into its target markets with commercially viable products in the United States and now continues to gain market share in the U.S. and internationally.
Gary Grieco, CEO and Chairman, PCT LTD
+1(843) 390-7900 Office
October 20, 2020 https://www.ahsn-nenc.org.uk/blog/celebrating-infection-prevention-innovators/
"Celebrating infection prevention innovators" - Academic Health Science Network (U.K.)
20th October 2020
COVID-19 has drawn huge attention to the importance of infection prevention and control. This year, International Infection Prevention Week (#IIPW) celebrates the importance
of infection prevention and the role we all play in protecting public health whilst giving thanks and recognising the vital job of our healthcare Infection Preventionists.
In this blog, Charlotte Fox, Innovation Manager, shines the spotlight on an innovative disinfection solution which has been supported by the AHSN NENC. International Infection Prevention Week gives people the opportunity to share their good practice and to join the national conversation to raise the awareness of essential standard infection control precautions, hand hygiene, safe distance and clean environments amongst many others. My role at the AHSN NENC is to support our region’s NHS Trusts to innovate and one of the most exciting innovations I’ve supported this year is the PCT Health Annihilyzer with North Tees and Hartlepool NHS Foundation Trust and its subsidiary company and support services provider, NTH Solutions. With funding from the AHSN NENC, North Tees & Hartlepool NHS FT were able to carry out evaluation work with partners PCT Health to explore a revolutionary disinfection solution.
PCT Health’s Annihilyzer system is unique, the system uses Hypochlorus fluid (HOCl) which is a broad-spectrum disinfectant. It is hospital made and proven to kill 99.9999% of known Hospital Associated Infection (HAI) pathogens. The disinfectant solution is composed of salt and water so is PH neutral and enables daily deep cleaning and removes the need to close off wards and treatment rooms to allow for cleaning. NTH Solutions also offers a commercial deep cleaning service utilising the PCT Health Annihilyzer and has created 50 job posts to assist both the Trust and its subsidiary NTH Solutions. You can read more about the system on NTH Solution’s website here https://nthsolutions.co.uk/services/the-annihylyzer/
The Economic Growth team are extremely pleased to support such an innovative product and this service really highlights the support that we provide to innovators across the NHS system. Infection prevention control seems particularly relevant during this time and being able to offer support to NTH Solutions and North Tees and Hartlepool NHS Foundation Trust for this project has been a real highlight for the team. If you’d like to find out more about the PCT Annihilyzer system, please email firstname.lastname@example.org and if you would like to find out how the Economic Growth team can support your innovation, please email email@example.com. April 17, 2020
Little River, SC -- April 17, 2020 -- InvestorsHub NewsWire -- PCT LTD (OTC Pink Current Information: PCTL ) is pleased to announce new growth and expansion activities in the UK and NYC. PCT Europe Ltd, the UK-based partner of PCTL is pleased to announce they have signed an exclusive trading partnership/distributor agreement with a NHS (UK National Health Service) company. In tandem with PCT Europe Ltd, the UK NHS company will introduce PCT technology to each NHS Hospital Trust with the intention of them rolling out PCT's unique technology and system throughout the health services' 233 Trusts comprising over 600 hospitals. In addition, approximately 14,000 Care Homes in the UK will also be introduced to PCT's technology. A steady flow of orders is expected to commence throughout the remainder of 2020 and into 2021. The first PCT system has now been installed in a large NHS [UK National Health Service] hospital in the north of England. This system is expected to enter clinical service early in May 2020, once the final series of biological tests of the PCT hospital disinfectant solution have been completed. Results of these tests have so far demonstrated the PCT disinfectant has met of exceeded its ability to kill the range of pathogens previously achieved during EPA [Environmental Protection Agency] tests. More updates to follow.
Investors Conference Call 02/20/2020
PCT LTD Discusses Their International Expansion and Growth Strategy with Stock Day Podcast
PCT LTD Issues Company Update and Signs Collaborative Agreement for Oil & Gas, and Cannabis Applications
"Ten (10) Annihilyzer® Infection Control Systems have been installed in seven (7) different hospitals, including one in the United Kingdom, and three (3) more are slated for installation within the next several weeks."
PCT LTD Continues to Expand by Signing Long-Term Agreement with ACE
LITTLE RIVER, S.C., October 31, 2019
PCT LTD (OTC Pink: PCTL), through its operating subsidiary Paradigm Convergence Technologies Corporation (“PCT Corp.”) continues to provide its world class cleaning and disinfection systems to hospitals at a rapid rate. A continuing flow of orders, both domestically and internationally, is expected moving forward. Read Full Press Release
Contact Information Investor Relations Contact: Mike Lorlano Tel: (760) 621-0062 Mike@mountaintopmedia.net
Welcome to Paradigm Convergence Technologies Corporation
Paradigm Convergence Technologies Corp (PCT) is a technology licensing company specializing in environmentally safe solutions for global sustainability. The company provides innovative products and technologies for eliminating contamination from water supplies, industrial fluids, hard surfaces, food processing equipment, and medical devices.
Preventing Microbial Infections
Many billions of dollars a year are spent by individuals, organizations and the health care system to treat people who get infectious diseases caused by microbes including bacteria, viruses and fungi. With the advent of adaptive and ever more dangerous microorganisms called “super bugs”, the danger of acquiring life-threatening infections is real and growing. This danger affects everyone anytime they are in space where people gather, any microbe contaminating that space is a possible source of infection. With American’s spending 20 or more hours a day indoors, much of it in spaces that are not cleaned and sanitized/ disinfected properly, the threat of infection is constant, growing and dangerous, particularly to our vulnerable populations of the very young, elderly and infirm.
Infectious diseases were associated with an economic burden of over $120 billion in the U.S. in 2014. Antibiotic resistant infections cost Americans $20 billion in direct medical costs and $35 billion in lost productivity in 2014. A particularly acute problem is Hospital Acquired Infections (HAIs) which are increasingly hard to kill or treat effectively. As a result, doctors struggle to contain, fight and cure increasingly antibiotic resistant infections such as MRSA, and C. Diff. The more antibiotics, medicines, pesticides and disinfectants are used to kill them, the quicker the microorganisms adapt, becoming ever stronger and more drug-resistant. Researchers estimate that, if the U.S. could reduce the number of hospital-acquired infections by 20%, healthcare providers would save nearly $7 billion per year. Insurance companies are beginning to deny coverage for treatment of HAIs, forcing hospitals to self-insure. This will create an immense financial and risk-management burden on hospitals, long-term medical, rehabilitation and assisted living facilities.
Overcoming the problem of microbial contamination and infectious disease can be straightforward. It requires proper products, equipment, protocols, education, and training for comprehensive and reliable cleaning, sanitizing and disinfecting solutions.PCT Corp. offers these with its comprehensive “Green Cleaning” and Infection Control Systems. Infectious microbes cannot develop resistance to the cleaning and sanitizing products PCT Corp. uses and they are much less toxic to humans or pets than traditional agents such as bleach and ammonia.
The products are used through a commercially-ready, patented, integrated product and technology solution for total facility cleaning and sanitizing. This system and solution, The PCT Annihilyzer® Infection Control System, was specifically designed for use in hospitals, assisted-living and nursing homes and other large facilities. In various configurations, the solution system can be deployed in urgent care centers, medical, dental and veterinary practices and other health care facilities. A complete and custom turn-key cleaning, sanitizing and disinfection program solution can be provided to each facility. It is also adaptable to deployment in schools, prisons, hotels and many other facilities.
PCT has launched a major marketing and sales effort in the hospital facilities market and The PCT Annihilyzer® System has now been deployed in several hospitals in the eastern U.S.
Learn more about The PCT Patented Annihilyzer® System
PCT PRODUCTS AND APPLICATIONS
The Annihilyzer® System
The Survivalyte System
Large Volume Systems
Small Volume Systems
Hospital-acquired infections (HAI) — also known as a nosocomial infection — is an infection that is contracted from the environment or staff of a healthcare facility. It can be spread in the hospital environment, nursing home environment, rehabilitation facility, clinic, or other clinical settings. In the United States, the Centers for Disease Control and Prevention estimated roughly 1.7 million hospital-associated infections, from all types of microorganisms, including bacteria and fungi combined, cause or contribute to 99,000 deaths each year.
Our goal is to provide solutions to this issue, by outfitting a healthcare setting with the technology and guidance needed to effectively get the job done - all through a dedicated partnership to prevent and eradicate the spread of infectious disease.
Oil and Gas:
Waste Water Treatment
Our system helps to decontaminate “frac” water for reuse in the fracking process, saving the industry millions of dollars and preserving the world’s water supply. Some of the many benefits of our system/process include: Elimination of highly toxic chemicals currently used for decontamination, reduced negative environmental impact, reduced recovery costs and potentially opening new areas for oil and gas retrieval.
Turning “Sour” Crude Oil to “Sweet”
In other areas in the gas and oil industry that presents a challenge is in treating existing wells for the presence of H2S of hydrogen sulfide. H2S is a large and growing problem in the industry, due to its continued introduction of bacteria in the fracking process. H2S causes increased production costs. Our solutions reduce those costs and reduce the environmental impact.
In the agriculture world, through USDA grants and multiple studies by universities around the world, Hypochlorous acid solutions have been tested and proven effective against yield-reducing crop pathogens in post-harvest applications to include sanitizing at point of harvest, point of packing and points of sale.
We are hoping to help stop these crop-devastating pathogens with our hypochlorous solutions that are known to be environmentally responsible and designed to improve and maintain crop yields, to produce a healthier overall harvest.
Dedicated to the success of students, schools are faced with a multitude of challenges to reach their goal of providing a solid education and an environment for healthy growth. To add to the list of responsibilities of school administrators, the battle of keeping absenteeism down, preventing the spread of infectious disease and keeping a clean environment bears a heavy load. Not only are the traditional cleaning products losing their effectiveness - thus allowing drug/antimicrobial resistant pathogens to wreak havoc - they are also polluting the indoor air with volatile organic compounds (VOCs) that are known to cause respiratory-related issues, headaches and other ailments.
By providing daycare facilities, school systems and universities with a better alternative to poisonous, caustic chemical cleaning/antimicrobial agents, we’re providing a more productive environment. Not only are you killing germs with a product that eradicates them completely - keeping them from becoming resistant - you’re doing so with a product that doesn’t cause harm to the user, students or faculty.
Hotel and Tourism:
Similar to the healthcare environment, the hotel and tourism industry (i.e resorts, airports, cruise ships, etc.) are subject to communicable diseases. In the healthcare market, they are referred to as Hospital-Acquired Infections/Healthcare-Associated Infections (HAIs) and in the hotel and tourism industry, they are known as Community-Acquired Infections. With as many different people traveling through these areas, from all sorts of countries and carrying various types of ailments or pathogens with them, consider the potential for an uncontrollable spread of these germs.
Outbreaks are typically caused by lack of proper processes and/or a failing product. Our ECA technology is designed to help anyone in the industry to get a grip on the issue and succeed at their main goal: providing an awesome experience for their guests.
Our sanitizer strength solution meets the requirement of the FDA and USDA, to be a non-rinse sanitizing agent. In the world of dealing with food, why not use a product that actually kills food-borne pathogens - without containing any toxic chemicals that would harm the quality of the product?
Whether you’re dealing with meat, poultry or just need to maintain a facility’s defense against Salmonella/E. coli, contact us about using our solutions
- The Solution: ECA Technology
Germ Killing Power:
Forget harsh, toxic chemicals. Our process only requires salt, water and electricity to produce two products –a chlorine-based antimicrobial agent and an excellent degreasing cleaner.
Our technology produces an effective variable PPM hypochlorous acid solution that is created through an electrolytic process called Electro-Chemical Activation (ECA). It occurs by temporarily modifying the properties of water, by passing weak salt brine through an electrolytic cell and temporarily changing the properties of the salt water into a powerful oxidizing agent exhibiting highly effective antimicrobial properties.
An Excellent Cleaner:
Catholyte or sodium hydroxide, is an aqueous solution that is the natural byproduct of the electrolysis process, and is used to reduce microbe contamination and soil loads that can harbor germs on hard surfaces.
Catholyte is also a very effective degreaser and is a great option to safely clean floors without hazardous fumes, thus improving indoor air quality.
PCT LTD Deploys Initial Annihilyzer(R) Infection Control System to the United Kingdom
Little River, South Carolina--(Newsfile Corp. - October 22, 2019)
PCT LTD (OTC Pink: PCTL), a Little River, South Carolina company and the designer of the Annihilyzer® Infection Control System, a world class whole room cleaning and disinfecting system for hospitals and health care facilities, is pleased to announce that it has shipped the first overseas Annihilyzer® Infection Control System to its partner company, PCT Europe Ltd., in the United Kingdom.
Read press release
PCT LTD Announces Additional Hospital Installation of Annihilyzer® Infection Control System
LITTLE RIVER, S.C., October 7, 2019
PCT LTD (OTC Pink: PCTL), through its operating subsidiary, Paradigm Convergence Technologies Corporation (PCT Corp), announces another successful phase one installation of PCT Corp.’s Annihilyzer® Infection Control System in coordination with its primary healthcare distributor, ACE Janitorial Services. PCT Corp. installed the premier cabinet model of its Annihilyzer® Infection Control System this week at Mount Sinai South Nassau Medical Center located in Oceanside, NY.
PCT LTD Announces New Purchase Order as the Result of a Successful Trial of Annihilyzer® Infection Control Systems
LITTLE RIVER, S.C., May 6, 2019
PCT LTD (OTC Pink: PCTL), through its operating subsidiary, Paradigm Convergence Technologies Corporation (PCT Corp), announced today that ACE Janitorial Supply Company (“ACE”), PCT Corp.’s distributor for the New York hospital and healthcare market, received a new purchase order for Morgan Stanley Presbyterian Children’s Hospital to continue using PCT Corp.’s patented Annihilyzer® Infection Control System following a successful 60-day trial within the facility. Morgan Stanley Presbyterian Children’s Hospital is the fourth hospital to become a customer of PCT Corp’s. and to take a proactive approach in providing patients, visitors and staff a new type and level of protection from the potential of hospital-associated infections.
PCT LTD Installs a Large Volume Hydrolyte® System with Option Agreement for 4 additional LVH Systems with Oil & Gas Industry Customer
LITTLE RIVER, SC, February 25, 2019
PCT LTD (OTC Pink: PCTL), through its operating subsidiary, Paradigm Convergence Technologies Corporation (PCT Corp), a leader in environmentally safe, non-toxic, antimicrobial solutions announced today it has sold and is currently installing a large volume C-104 Hydrolyte® Systems to an existing customer, H2S Safe Treat, Inc. of Ada, OK (H2S). H2S requested and has agreed to an option to purchase four more C-104 Systems at the agreed pricing schedule on or before September 15, 2019. H2S currently operates a lower volume C-102 system purchased in July 2018 for the generation of fluids used in its proprietary treatment process, which removes environmentally and commercially harmful Hydrogen Sulfide (H2S) from crude oil and natural gas. H2S is expanding the beta field-testing of its proven treatment and decontamination processes as it moves toward commercial scale operations.
PCT LTD Continues Expansion throughout New York Major Hospitals with its Patented Annihilyzer® Infection Control Systems
LITTLE RIVER, S.C., Feb. 21, 2019
PCT LTD (OTC Pink: PCTL), through its operating subsidiary, Paradigm Convergence Technologies Corporation (PCT Corp), a leader in environmentally safe, non-toxic, antimicrobial solutions for infection control, announced today its continued expansion and recognition throughout the State of New York for its patented Annihilyzer® Infection Control System.
PCT LTD Receives Additional Purchase Order for Two Large Volume Hydrolyte® Systems from Existing Food Processing Customer
LITTLE RIVER, SC, February 12, 2019
PCT LTD (OTC Pink: PCTL), through its operating subsidiary, Paradigm Convergence Technologies Corporation (PCT Corp), a leader in environmentally safe, non-toxic, antimicrobial solutions announced today it has received a repeat order for two large volume Hydrolyte® Systems from one of its existing food processing customers. The referenced food processing customer’s plant currently has two systems at one facility and purchased another large volume system from PCT as a result of their 2018 plant expansion.
PCT LTD enters into Manufacturers Representative Agreement for Sales of Annihilyzer® Infection Control Systems in the Ohio Valley Region.
LITTLE RIVER, SC February 7, 2019
PCT LTD (OTC Pink: PCTL), through its operating subsidiary, Paradigm Convergence Technologies Corporation (PCT Corp), a leader in environmentally safe, non-toxic, antimicrobial solutions for infection control, announced today it has entered into a Manufacturer’s Representative Agreement with DTS of Cleveland, OH (DTS), for the sale of Annihilyzer® Infection Control Systems in Ohio, West Virginia, Western Pennsylvania, Michigan, Indiana and Kentucky.
PCT LTD Executes New Master Service Agreement for Installation of Annihilyzer® Hospital Infection Control System at Carson Tahoe Regional Medical Center
LITTLE RIVER, S.C., January 10, 2019
PCT LTD (OTC Pink: PCTL), through its operating subsidiary, Paradigm Convergence Technologies Corporation (PCT Corp), a leader in environmentally safe, non-toxic, antimicrobial solutions for infection control, secured a three-year Master Service Agreement and recently installed its Annihilyzer® Infection Control System at Carson Tahoe Regional Medical Center in Carson City, NV. Carson Tahoe conducted in-house evaluations at their facility and produced several articles regarding the use of Hypochlorous Acid for cleaning and disinfecting surfaces in a hospital environment to reduce colony forming microorganism contamination. Hospital Associated Infections (HAI’s) currently costs U.S. hospitals over $35 Billion in infection prevention and control programs, HAI patient treatment and other significant HAI-associated costs.
PCT Ltd Secures Contract for 2 Annihilyzer® Hospital Infection Control Systems in Brooklyn Hospital
Little River, South Carolina, November 1, 2018
PCT LTD’s operating subsidiary, Paradigm Convergence Technologies Corporation (PCT Corp), announced today that, with its New York-based representative, it has entered into a contractual agreement for the installation and operation of two Annihilyzer® Infection Control Systems in a major Brooklyn hospital. The installation of the systems is currently underway and near completion.
Read Press Release
PCT Ltd enters into Master Services Agreement for Installation of Annihilyzer® Infection Control Systems in the Greater New York Area
Little River, South Carolina, October 26, 2018
PCT LTD’s operating subsidiary, Paradigm Convergence Technologies Corporation (PCT Corp), announced today it has entered into a Master Services Agreement with a New York-based hospital supply and services company for the installation of two Annihilyzer® Infection Control Systems to prevent hospital-acquired infections (HAI’s) in hospitals in its market area.
Read Press Release
GREAT NEWS IS THAT THE ALERT BELOW DOES NOT
AND WILL NOT APPLY TO PCTL BECAUSE PCTL FLUID IS APPROVED
BY THE EPA TO KILL THE COVID19 VIRUS AND NO FALSE CLAIMS
HAVE BEEN MADE BY PCTL
* EPA Approved List B: Tuberculocide Products Effective Against Mycobacterium tuberculosis
* EPA Approved List C: Antimicrobial Products Effective Against Human HIV-1 Virus
* EPA Approved List F: Antimicrobial Products Effective Against Hepatitis C
* EPA Approved List G: Antimicrobial Products Effective Against Norovirus
* EPA Approved List N: Disinfectants for Use Against SARS-CoV-2
* Green Seal Certified Equipment https://www.sec.gov/oiea/investor-alerts-and-bulletins/ia_coronavirus
THE SEC LINK IMMEDIATELY ABOVE
DOES NOT APPLY AT ALL TO PCTL.
Dear Valued PCTL Shareholders, As we approach the end of 2020, I wanted to take the time to address and discuss the current state of the Company. This past year the coronavirus has been devasting for so many people and business, but it has created significant growth opportunities for PCT LTD. We are currently wrapping up our greatest year ever. This year we have experienced record-breaking revenue growth and we are a much stronger company today than when 2020 began. It was not that long ago that we were in survival mode. Fortunately, we are well beyond survival mode and firmly into growth mode. Today, we get up each morning excited to make progress on the trajectory of growth we are currently on. Our focus is to develop new ways to expand into different markets and provide innovative solutions for our target customers. In addition to the great strides we have taken, the best is yet to come. COVID-19 has revealed how important our services are and has created one of those rare moments in history that will forever change the way we do many things we used to take for granted. It has made us much more aware of the presence of contagions and the ease of their transmission and has resulted in changes in the way we interact with each other that will continue as our new normal, even if the current vaccine is successful. This past year has also been a year of new milestones for our company, not the least of which has been considerable revenue growth in each quarter of 2020 over the same period of 2019: 38.9% revenue increase in Q1 2020 over Q1 2019, 640% revenue increase in Q2 2020 over Q2 2019, 256% revenue increase in Q3 2020 over Q3 2019, 262% revenue increase for the first 3 quarters of 2020 compared to the same period in 2019, $1,937,442 in revenues for the first 3 quarters of 2020 compared to $534,852 for the same period in 2019. Basic and diluted net loss per share decreased from 0.03 in Q3 2019 to 0.01 in 2020. Additionally, basic and diluted net loss per share decreased from 0.10 for the nine months ending in September 2019 to 0.02 for the nine months ending in September 2020 We kicked off our international expansion efforts early in the year when we shipped our very first Annihilyzer to the United Kingdom to begin trials abroad. As we expected, the trials were successful and resulted in the first of what we anticipate will be many European purchase orders. One of our ongoing objectives is to continually grow our number of distributors. We recognize the importance of strategically expanding this network and are actively enlarging our footprint in order to better serve a greater number of geographical regions and markets. We currently have 25 active domestic distributors covering 17 states and Puerto Rico. We continually have ongoing discussions with other future distributors in key markets that we expect will be finalized soon. We have increased our fluid production capabilities to 10,000 gallons per day out of our Little River, South Carolina location. Additionally, we are near completion of our new facility in Fort Wayne, Indiana which will have initial fluid production capability of 4,000 gallons per day. This facility is well situated to serve the product needs of the Midwest. As we announced last month, we began 2020 with a significant amount of toxic debt on the books in the form of six convertible notes. Those notes were backed by shares of stock with floating conversion prices, heavy penalties, warrants and interest amounting to approximately $2,150,000. These notes were convertible at a significant discount to the market price and also had 447,670,272 warrants attached, exercisable at $0.00165 per share. We had a clear objective of ridding ourselves of this debt in the most fiscally responsible way possible and we accomplished that goal. It took months of negotiations, but we were able to settle the $2,150,000+/- of debt for only $625,000 and the issuance of 123,000,000 shares of common stock. As a result of those settlements, we were able to cancel all 447,140,272 warrants. PCTL applied to the OTC Markets for listing on the OTCQB in the fall of this year. Several rounds of comments were completed and, with the recent settlement of our last 2019 convertible note, we believed we had satisfied the evolving OCTQB requirements. We are in the final stages of addressing all comments from the OTC Markets Compliance Team. Provided there are no more questions or comments, the process will proceed in queue with OTC Markets for the jump to the OTC:QB listing. Among the many sales we have executed this year, one is of special importance; our 1,000,000 gallon domestic supply agreement with Maverick Energy Services and Maverick Environmental Solutions of Holdenville, Oklahoma. This will be split among two Maverick companies covering both their oil and gas and non-oil and gas customers. Fulfillment of the contract is anticipated to provide millions of dollars of gross revenues to PCTL and represents a significant entrance into the oil and gas sector for our company. Our hospital presence has more than doubled in 2020, growing from 5 hospitals when we started the year to our current year-end total of 12. PCT LTD is much better positioned today to increase this sector of our business than we were this time last year. With new sales and marketing programs being designed and implemented for, we expect to experience substantial expansion into additional hospitals across various new geographic areas in 2021. When 2020 began, our company’s entire production came from the efforts of nine full-time employees. Our growth over the past twelve months has necessitated the expansion of our workforce to keep up with our rising business demands. As we close out the year, we have more than doubled our workforce from nine to twenty. Twelve are full-time employees, three are part- time employees and five are independent contractors. We anticipate continued personnel increases will be needed soon and throughout the coming year to keep pace with our projected business growth. At this time, we are gearing up for larger expansion and revenues as our initial $10 million dollar revenue guidance in 2021 suggested. We are bringing on our new, highly qualified CFO and Legal Counsel, Sheldon Smith at the beginning of 2021. We also anticipate greater public exposure and awareness through more effective marketing and a much needed and warranted increase in our share value in 2021). We intend to make our brand THE recognized brand as THE preventive solution for use against unwanted and dangerous microorganisms in healthcare, oil & gas and within the agricultural industries. We are appreciative of all our shareholders who have been supportive of our efforts during this past year. We want you to know that we are committed to making PCT LTD one of the elite companies in our industry. We will be tireless in our efforts to increase shareholder value by seeking new opportunities for expansion and continuing to strengthen our company as we take it to new heights in 2021. We wish you all a Happy, Healthy and Prosperous New Year. Sincerely, Gary Grieco CEO and Chairman PCT LTD PCTL Shareholder patiently wait for Q4 2020 Fins. When it hits, it's gonna be HUGE! GO PCTL!!! ROLL, PCTL, ROLL!!! WRONG AND NOTED.
"Toxic Financing" above is Fake News! Disproven by a Ton of Recent DD (2021) on PCTL.
Manipulators that missed out on PCTL at 1¢ want reduce PCTL's share price to get in low.
MARCH 2, 2021 - OILFIELD TESTS RESULTS
ROLLING IN. PCTL GONNA BE A GUSHER!!! OTC Markets Status: Pink Current Info 4/13/21
OTC Markets Financials: Current as of 4/13/21 Roll, Paradigm Convergence Techno, Roll! - AD 2021